Profile data is unavailable for this security.
About the company
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
- Revenue in USD (TTM)14.75m
- Net income in USD-10.66m
- Incorporated2012
- Employees61.00
- LocationEkso Bionics Holdings Inc101 GLACIER POINT, SUITE ASAN RAFAEL 94901United StatesUSA
- Phone+1 (510) 984-1761
- Fax+1 (702) 866-2689
- Websitehttps://eksobionics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guided Therapeutics Inc | 178.00k | -2.80m | 26.75m | 4.00 | -- | -- | -- | 150.29 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 28.28m | 143.00 | -- | 0.5745 | -- | 0.8876 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Femasys Inc | 2.06m | -19.80m | 29.72m | 69.00 | -- | 5.28 | -- | 14.42 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| Myomo Inc | 41.64m | -12.02m | 31.53m | 184.00 | -- | 2.16 | -- | 0.7571 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Vaso Corp | 89.11m | 2.59m | 31.67m | 298.00 | 12.26 | 1.12 | 9.56 | 0.3554 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 31.76m | 117.00 | 54.37 | -- | -- | 6.15 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 33.49m | 61.00 | -- | 2.67 | -- | 2.27 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 34.21m | 10.00 | -- | 4.23 | -- | 36.86 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| TELA Bio Inc | 77.06m | -39.00m | 34.54m | 209.00 | -- | 20.45 | -- | 0.4483 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| Modular Medical Inc | 0.00 | -24.22m | 35.22m | 54.00 | -- | 3.16 | -- | -- | -0.5081 | -0.5081 | 0.00 | 0.1434 | 0.00 | -- | -- | 0.00 | -222.79 | -171.42 | -294.38 | -207.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.75 | -- | 57.07 | -- |
| Vivos Inc | 48.63k | -3.01m | 35.42m | 10.00 | -- | 16.25 | -- | 728.32 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Precision Optics Corporation Inc | 21.58m | -6.11m | 36.75m | 90.00 | -- | 3.36 | -- | 1.70 | -0.8505 | -0.8505 | 3.01 | 1.42 | 1.09 | 5.00 | 5.90 | 239,722.70 | -30.82 | -13.63 | -45.79 | -19.51 | 14.99 | 29.56 | -28.30 | -11.58 | 0.785 | -28.85 | 0.1375 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 39.31m | 64.00 | -- | 4.22 | -- | 13.21 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
| Cytosorbents Corp | 34.35m | -10.59m | 40.28m | 149.00 | -- | 4.47 | -- | 1.17 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| Precipio Inc | 22.80m | -1.25m | 40.98m | 54.00 | -- | 2.97 | 169.34 | 1.80 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 41.01m | 18.00 | -- | 5.75 | -- | 3.39 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
Data as of Feb 17 2026. Currency figures normalised to Ekso Bionics Holdings Inc's reporting currency: US Dollar USD
4.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Citadel Securities LLCas of 30 Sep 2025 | 38.55k | 1.14% |
| Geode Capital Management LLCas of 31 Dec 2025 | 25.21k | 0.74% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 18.65k | 0.55% |
| Cresset Asset Management LLCas of 30 Sep 2025 | 17.96k | 0.53% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 16.80k | 0.50% |
| Shay Capital LLCas of 30 Sep 2025 | 13.00k | 0.38% |
| Virtu Americas LLCas of 30 Sep 2025 | 11.11k | 0.33% |
| IMPact SGR SpAas of 30 Sep 2025 | 3.67k | 0.11% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.65k | 0.11% |
| Banque Lombard Odier & Cie SA (Investment Management)as of 31 Dec 2025 | 1.67k | 0.05% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
